Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment-Reference-Cited by-同舟云学术

Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment

Published:2013-10-22 Issue:10 Volume:109 Page:2523-2532
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Thiel U, ,Koscielniak E,Blaeschke F,Grunewald T G P,Badoglio M,Diaz M A,Paillard C,Prete A,Ussowicz M,Lang P,Fagioli F,Lutz P,Ehninger G,Schneider P,Santucci A,Bader P,Gruhn B,Faraci M,Antunovic P,Styczynski J,Krüger W H,Castagna L,Rohrlich P,Ouachée-Chardin M,Salmon A,Peters C,Bregni M,Burdach S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2013630.pdf

Reference49 articles.

1. Baird K, Fry TJ, Steinberg SM, Bishop MR, Fowler DH, Delbrook CP, Humphrey JL, Rager A, Richards K, Wayne AS, Mackall CL (2012) Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas. Biol Blood Marrow Transplant 18 (5): 698–707.

2. Bishop MR, Fowler DH, Marchigiani D, Castro K, Kasten-Sportes C, Steinberg SM, Gea-Banacloche JC, Dean R, Chow CK, Carter C, Read EJ, Leitman S, Gress R (2004) Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer. J Clin Oncol 22 (19): 3886–3892.

3. Bregni M, Bernardi M, Ciceri F, Peccatori J (2004) Allogeneic stem cell transplantation for the treatment of advanced solid tumors. Springer Semin Immunopathol 26 (1-2): 95–108.

4. Burdach S, van Kaick B, Laws HJ, Ahrens S, Haase R, Korholz D, Pape H, Dunst J, Kahn T, Willers R, Engel B, Dirksen U, Kramm C, Nurnberger W, Heyll A, Ladenstein R, Gadner H, Jurgens H, Go el U (2000) Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Dusseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria. Ann Oncol 11 (11): 1451–1462.

5. Carli M, Colombatti R, Oberlin O, Bisogno G, Treuner J, Koscielniak E, Tridello G, Garaventa A, Pinkerton R, Stevens M (2004) European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol 22 (23): 4787–4794.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials;Cancers;2023-03-30

2. Metastatic rhabdomyosarcoma: Evidence of the impact of radiotherapy on survival. A retrospective single‐center experience;Pediatric Blood & Cancer;2022-06-30

3. No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy;Frontiers in Oncology;2022-05-10

4. Relapsed Rhabdomyosarcoma;Journal of Clinical Medicine;2021-02-17

5. Allogeneic hematopoietic stem cell transplantation for alveolar rhabdomyosarcoma: the first clinical experience of haploidentical transplantation;Pediatric Hematology/Oncology and Immunopathology;2020-12-22